This content is from: Portfolio Is the Bitcoin Comeback for Real? “It’s pretty much uncontroversial that some crypto trading is manipulated.” By Michelle Celarier April 24, 2023
Sponsored Curetis Gets €9.6M VC Funding Germany’s Curetis AG has secured €9.6 million in venture capital financing. October 26, 2011
Henri Meier's genome project When Henri Meier retired from Roche last December, the longtime CFO had achieved near-legendary status for consistently producing returns of 25 percent or better on the Swiss drug company's investment portfolio. June 30, 2001
The Price of success Tradition and iconoclasm have made T. Rowe Price hugely successful. But is it being bold enough as shadows darken? December 14, 2005
This content is from: Portfolio Hedge Fund Rising Stars Show Commitment to the Greater Good Amid a technology and venture capital boom, these young professionals prove that hedge funds still attract the cream of the crop. By Georgina Hurst By Imogen Rose-Smith By Jess Delaney By Kaitlin Ugolik June 15, 2015
This content is from: Portfolio Is This The Future Of Big Pharma? Pharmaceuticals makers are experimenting with a variety of new business models, almost the same way they experiment with molecules, hoping to find a blockbuster that will save their bottom line. By Fran Hawthorne June 03, 2011